Nemes Rush Group »

Oncternal Therapeutics shares owned by Nemes Rush Group

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by Nemes Rush Group from 13F filings

Historical chart of Nemes Rush Group investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Nemes Rush Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Nemes Rush Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $23 3 7.67
2024-03-31 $27 3 9.00